application for an effect on pneumococcal carriage, we administered tetravalent inactivated influenza vaccine as a control (n = 62). LAIV infection led to transiently increased pneumococcal acquisition at day 2 (60.0% and 40.3%, as detected by molecular methods, in LAIV groups and control groups, respectively) 14 . LAIV also increased S. pneumoniae carriage load in the first 14 days following pneumococcal inoculation 14 (Supplementary Fig. 1 ). We collected a series of nasal microbiopsies and nasal lining fluid throughout the study to assess ongoing cellular and cytokine responses. Participants were grouped into those who did not become colonized following S. pneumoniae challenge (carriage − ) and those who did (carriage + ), as determined by classical microbiology (Fig. 1a ). To investigate whether LAIV-induced immune responses were associated with a predisposition to pneumococcal carriage, we measured the concentrations of 30 cytokines and of proteins, including interleukin 1 receptor antagonist (IL-1RA), in nasal lining fluid (Fig. 1b) . After multiple-testing correction, we found that at day 0, directly prior to S. pneumoniae inoculation, LAIV significantly increased concentrations of 20 cytokines, including CXCL10 (IP-10), tumor-necrosis factor (TNF), interleukin 10 (IL-10), IFN-γ and IL-15 ( Fig. 1b and Supplementary Table 1 ). In contrast, the control group did not show any significant increase in cytokine response at day 0. Following S. pneumoniae inoculation, S. pneumoniae carriage in the absence of LAIV was associated with increased concentration of epidermal growth factor at day 2 and decreased concentration of IL-1RA at day 9 after S. pneumoniae inoculation (compared with that at baseline), neither of which remained significant after multiple-testing correction. No other cytokines, including IL-17A or CCL2, were significantly altered by carriage alone (Fig. 1b) .
Even before bacterial inoculation, nasal inflammatory responses to LAIV differed between those who went on to become carriers and those who were protected from carriage (Fig. 1c) . In particular, IL-10 was significantly increased in LAIV-vaccinated subjects who did not acquire S. pneumoniae following inoculation (5.8-fold increase), but not in those who became carriers following inoculation (2.0-fold increase). In contrast, CXCL10 was significantly increased in subjects who went on to become carriers (2.4-fold increase), but not in those who remained carriage-negative (1.5fold increase). Moreover, subjects with increased concentrations of CXCL10 before inoculation displayed higher pneumococcal load following S. pneumoniae inoculation (Fig. 1d ). This suggests that differences in the response to influenza virus are associated with secondary susceptibility to S. pneumoniae. To test whether this was specific for LAIV infection, we measured CXCL10 in nasal washes from an independent cohort in which a subset of subjects had an asymptomatic viral upper respiratory tract infection the week before S. pneumoniae inoculation that did not progress to symptomatic infection. These comprised infections with rhinovirus (n = 12), coronavirus (n = 5), respiratory syncytial virus (n = 2) and parainfluenzavirus (n = 1) 29 . The predominant virus, rhinovirus, was recently shown to associate with increased pneumococcal acquisition and transmission 30 . In these virus-infected subjects, CXCL10 concentration was increased ( Supplementary Fig. 2 ), and baseline CXCL10 concentration correlated with increased pneumococcal load also in this second cohort ( Fig. 1e ). Unfortunately, sample sizes were too small to further investigate in depth the effects of infection with the different viruses, which are likely to have divergent consequences. Although the correlation was modest in this validation cohort, suggesting that other host and environmental factors are involved, we identified a biomarker, CXCL10, that was predictive of S. pneumoniae load.
Early neutrophil degranulation in response to carriage is impaired by LAIV infection. In mouse models, neutrophil recruitment after onset of carriage contributes to control of the bacteria 15 .
We observed pre-existing high numbers of neutrophils in the human nasal lining, and pneumococcal carriage did not lead to significant further recruitment of neutrophils ( Supplementary Fig. 3a ,b). To investigate whether luminal neutrophils were involved in the early control of carriage, we measured concentrations of myeloperoxidase, a marker for neutrophil degranulation 31 , in nasal washes. Concentrations were increased (2.2-fold) at 2 days after challenge in control carriage + but not carriage − individuals ( Fig. 2a ). This neutrophil activation was impaired in the LAIV group, who displayed high carriage load during early carriage and had increased acquisition compared with that of controls. Together, these findings suggest that neutrophil degranulation is important for the initial control of carriage. To investigate whether neutrophils were also impaired systemically following LAIV, as reported during wild-type influenza infection 32 , we isolated blood neutrophils before, and at 3 days after, LAIV administration from a subset of subjects. We confirmed that opsonophagocytic killing (OPK) of S. pneumoniae by blood neutrophils was decreased following LAIV ( Fig. 2b ). This effect could be mimicked by the addition of TNF, but not CXCL10, to neutrophils from healthy donors in vitro, decreasing killing capacity in a dosedependent manner ( Fig. 2c,d ). NanoString expression analysis of 594 genes revealed ten differentially expressed genes in blood neutrophils 3 days post-LAIV (Supplementary Table 2 ). Among those were the genes encoding MAP4K2 (mitogen-activated protein kinase kinase kinase kinase 2; 3.2-fold increase), which acts on the TNF signal-transduction pathway 33 , and the co-inhibitory receptor TIGIT (T cell immunoreceptor with immunoglobulin and ITIM domains; 3.6-fold increase; Fig. 2e ). TIGIT expression levels were also negatively correlated with neutrophil killing capacity (r = − 0.73; Fig. 2f ). TIGIT is an immunological checkpoint protein that has been described to promote regulatory T cell function 34 , but its expression on neutrophils has not been previously appreciated, to our knowledge. Incubation of whole blood with recombinant TNF increased TIGIT levels on neutrophil surfaces within 30 min in a dose-dependent manner ( Fig. 2g ). Taken together, these findings indicate that inflammation following LAIV impairs the response of nasal and systemic neutrophils to pneumococcus, which could be mimicked by addition of exogenous TNF to neutrophils and is associated with an upregulation of TIGIT.
Pneumococcal carriage-induced monocyte recruitment to the nose is impaired by LAIV infection. Immunophenotyping revealed a significant recruitment of monocytes to the nose following establishment of carriage ( Fig. 3a and Supplementary Fig. 4 ). Monocyte numbers increased as early as 2 days following S. pneumoniae inoculation, peaked at 9 days (median 4.8× increase) and remained elevated 29 days after S. pneumoniae inoculation. In contrast, there was no recruitment of CD3 + T cells to the nose ( Supplementary Fig. 4b ).
LAIV infection prior to pneumococcal carriage impaired the recruitment of monocytes to the nose (Fig. 3a ). Moreover, peak pneumococcal load was associated with increased monocyte recruitment in the control group, but not in the LAIV group (Fig. 3b,c) . Indeed, for subjects in the control group with very low carriage densities, which were detectable only by molecular methods, no monocyte recruitment was observed ( Supplementary Fig. 4c ). This suggests that a minimum S. pneumoniae load is required for sensing and monocyte recruitment and that LAIV infection interferes with this process. Although CCL2 (MCP-1) was not substantially induced following S. pneumoniae carriage, its concentration was correlated with numbers of monocytes at all time points ( Supplementary Fig. 5a ). Furthermore, stratification of individuals showed that those with increased CCL2 concentration at day 2 after S. pneumoniae inoculation exhibited increased monocyte recruitment ( Supplementary  Fig. 5b ). Concentrations of IL-6, IFN-γ and TNF were also correlated with numbers of monocytes at each time point, but stratification of individuals did not reveal differential recruitment of monocytes ( Supplementary Fig. 5a,b) . In a second, independent cohort that did not receive any vaccine, monocytes were increased at day 9 following S. pneumoniae inoculation, which was correlated with an increased CCL2 concentration in nasal fluid, validating these results ( Supplementary Table 3 and Supplementary Fig. 5c ).
Thus, acquisition of pneumococcal carriage led to a recruitment of monocytes to the nasopharynx, a process that was associated with pneumococcal load and CCL2 induction and that was inhibited by LAIV infection. Nasal responses associated with pneumococcal clearance are impaired by LAIV. To assess anti-pneumococcal responses induced by carriage, we collected nasal cells 29 days after S. pneumoniae inoculation, stimulated them in vitro with heat-killed S. pneumoniae and measured concentrations of 30 cytokines in the supernatant. Increased production (fold change > 2 and q < 0.05 (P value corrected for multiple testing) to unstimulated control) of TNF, macrophage inflammatory protein 1α (MIP-1α ), IL-10, IL-6 and granulocyte-macrophage colony-stimulating factor upon restimulation was observed in the control carriage + group ( Fig. 4a and Supplementary Fig. 6a ). In the LAIV carriage + group, however, this boosting of anti-pneumococcal cytokine responses by rechallenge was absent ( Fig. 4a and Supplementary Fig. 6a ). The production of the above five cytokines correlated with decreased pneumococcal load at day 29 after S. pneumoniae inoculation, suggesting these responses are involved in S. pneumoniae clearance (Fig. 4b) . To test whether monocytes/macrophages were the source of these cytokines, we compared the cytokine signature from whole nasal cells with that from alveolar macrophages exposed to S. pneumoniae in vitro (Fig. 4c ). Relative cytokine production was highly correlated between the two cell populations, suggesting that nasal monocytes/ macrophages could be the source of these cytokines. This is supported by the observation that in carriers with low carriage load (detectable only by molecular methods), absence of monocyte recruitment was associated with absent S. pneumoniae-specific responses ( Supplementary Fig. 6b ).
In conclusion, carriage led to increased responses of nasal cells to pneumococcal stimulation, which was potentially due to the infiltration of monocytes. This was impaired by prior LAIV infection and was correlated with clearance of pneumococcal carriage ( Supplementary Fig. 7 ).
LAIV alters nasal gene-expression responses to carriage.
To identify gene signatures associated with the observed responses to pneumococcal carriage and infection with LAIV, we performed RNA sequencing on whole nasal cells at days − 5, 2 and 9 after S. pneumoniae inoculation ( Fig. 5 and Supplementary Table 4 ). Carriage without LAIV induced 834 and 176 differentially expressed genes (DEGs) at days 2 and 9, respectively (Fig. 5a ). These genes were enriched for pathways associated with gap junction trafficking and regulation (including GJA1, TJP1 and multiple GJB genes) and degradation of the extracellular matrix (including COL17A1, COL12A1, LAMA3 and KLK7). In the carriage − group, a smaller number of DEGs was observed (161 and 248 at days 2 and 9, respectively).
In the LAIV carriage + group, 936 and 711 DEGs were observed at day 2 and day 9, respectively. Surprisingly, despite the high concentrations of inflammatory cytokines observed in the LAIV carriage − group, only a relatively small number of DEGs were observed . Spearman non-parametric correlation test results and regression lines with shaded 95% confidence intervals are shown per cytokine. c, The cytokine profile from alveolar macrophages (median for six volunteers shown) exposed to S. pneumoniae for 18 h was compared with that of stimulated whole nasal cells (median of control carriage + group shown). Spearman non-parametric correlation test results and regression lines with shaded 95% confidence intervals are shown.
at days 2 and 9 (126 and 153, respectively). DEGs of carriage + subjects receiving LAIV and DEGs of carriage + subjects without LAIV showed very little overlap, with only 38 DEGs at day 2 and 2 DEGs at day 9 in common. Very little overlap was observed at the pathway level between these groups, indicating LAIV alters the natural responses to pneumococcus ( Fig. 5b and Supplementary Table 5 ). This could reflect transcriptome kinetics, due to altered differentiation and cellular activation, or it could reflect changes in cell migration to the nasal mucosa. The LAIV carriage + group showed enrichment for genes encoding molecules involved in the Toll-like receptor 3 (TLR3) signaling cascade, in retinoic acid-inducible gene I (RIG-I)/melanoma differentiation-associated protein 5 (MDA5)-mediated induction of IFN-α /β pathways and in IFN-γ signaling, which is in agreement with the induction of antiviral responses following LAIV vaccination 35 . Moreover, TLR4 signaling was also enriched in this group. The pneumococcal protein pneumolysin is sensed by TLR4 36 , and it is possible that the increased pneumococcal load following LAIV vaccination led to increased pneumolysin sensing. O-linked glycosylation of mucins, which are used by S. pneumoniae as a carbohydrate source for growth 37 , was also enriched in the LAIV carriage + group (including the genes ST3GAL4, GALNT7, GCNT3 and B4GALT5). ST3GAL4 encodes a sialyl transferase, and cleavage of sialic acids by the influenza neuraminidase has previously been shown to promote pneumococcal growth 38 . This finding supports a LAIV-mediated effect on pneumococcal growth through alterations of host factors. Common genes and pathways between the LAIVvaccinated carriers and control carriers include 'innate immune system' and 'signaling by interleukins' (IL1B, CLEC4E, CD55 and IL1RN). In conclusion, the genome-wide transcriptomic response to pneumococcal carriage was substantially altered on both the gene level and the pathway level by LAIV.
Gene modules associated with recruitment of monocytes. To identify sets of coexpressed genes post-LAIV and carriage, we used CEMiTool on the baseline-normalized data of LAIV and control groups, separately 39 . This modular expression analysis revealed genes that may act together or are similarly regulated during the immune responses to carriage and infection.
Genes in the control cohort were grouped into four coexpression modules, of which three were significantly enriched for known reactome pathways (Supplementary Data 1) . Module M1 was enriched in the carriage + group at day 9 after S. pneumoniae inoculation (Fig. 6a ). Numbers of monocytes were correlated with the average fold change count in this module, suggesting that these genes reflect the infiltration of monocytes (Fig. 6b ). To further investigate these monocytes, we performed gene set enrichment analysis on the module M1 genes using a list of genes from distinct monocyte subsets (Fig. 6c) 40 . These genes were enriched for classical CD14 + CD16monocytes and not for other monocyte subsets. Moreover, this module was enriched for genes related to 'chemokine receptors bind chemokines' and 'IFN-α /β signaling' (Fig. 6d ). Type I interferons have been shown to be required for the clearance of pneumococcal carriage in mouse models 41 , and these findings suggest that their activity in monocytes might be critical for this. CEMiTool also integrates coexpression analysis with protein-protein interaction data. Expression of the gene encoding the chemokine CXCL6 and that of the gene encoding its receptor CXCR2 were identified as hubs in module M1 ( Fig. 6e and Supplementary Data 1) . CXCR2 engagement has been shown to induce attachment of monocytes to the endothelial layer, initiating chemotaxis, which suggests this interaction could contribute to monocyte recruitment 42 . Module M3 was enriched for genes related to 'extracellular matrix organization' and 'collagen formation' (Fig. 7) .
For LAIV, we identified six distinct coexpression modules ( Supplementary Data 2) , which were strongly enriched for genes related to 'diseases associated with O-glycosylation of proteins' (module M1), 'immunoregulatory interactions between a lymphoid and a non-lymphoid cell' (module M3), 'chemokine receptors bind chemokines' (module M4) and 'interferon signaling' (module M5; Fig. 8 ). Indeed, the hubs of module M5 are well known type I interferon-related genes, such as ISG15, OAS1, OASL, IFIT1-3 and IFITM1. Taken together, our findings reveal that a strong local antiviral response is elicited in response to LAIV infection.
Discussion
This study addresses fundamental questions about the immune responses that control and clear S. pneumoniae carriage and how influenza infection can alter this control. By using a double experimental human challenge model with LAIV and S. pneumoniae, we revealed that S. pneumoniae carriage led to quick degranulation of pre-existing nasal neutrophils in the human nose and recruitment . c, The genes of M1 present with genes highly expressed in CD14 + CD16 − (578 genes), CD14 + CD16 + (108 genes) and CD14 − CD16 + (162 genes) 40 , showing the overlapping number of genes between M1 and monocyte subsets in parentheses. The overlap for significance was analyzed using the χ 2 test. d, Over-representation analysis of module M1 using gene sets from the Reactome Pathway database. e, Interaction plot for M1, with gene nodes highlighted.
of monocytes, promoting bacterial clearance. LAIV infection impaired these immune responses following carriage. LAIV is an attenuated influenza strain, and wild-type influenza viruses might have even more pronounced effects on the host response to pneumococcus. Carriage in the absence of LAIV was associated with only limited inflammation, corroborating the view of S. pneumoniae as a commensal bacterium that can asymptomatically colonize healthy adults 43 . In contrast, robust proinflammatory cytokine responses were measured following LAIV at both the protein-and gene-expression level. These results provide an explanation for the published finding that LAIV increased acquisition of S. pneumoniae and carriage load 14 .
In addition, our findings that LAIV led to impaired blood neutrophil killing capacity and that the addition of TNF, the nasal levels of which were increased following LAIV, to neutrophils in vitro impaired their activity highlight the crucial role of neutrophils in susceptibility to secondary bacterial infection 44 . The association of TIGIT with this impaired neutrophil function following influenza infection warrants further investigation, as TIGIT-blocking therapeutics are currently being developed for treatment of cancer and human immunodeficiency virus 45 .
We identified CXCL10 as a marker for increased susceptibility to S. pneumoniae, and we propose that this should be further investigated as a potential therapeutic target for secondary bacterial infections associated with viral infections. Our data showed that individuals with higher concentrations of CXCL10 prior to S. pneumoniae inoculation had higher bacterial loads. In a previous study, children with pneumonia with viral and bacterial (predominantly pneumococcal) co-infection had increased amounts of CXCL10 compared with those of children with only viral or bacterial pneumonia, a finding that is associated with disease severity 46 . Data in mice suggest that CXCL10 plays a direct role during pneumonia. Mice with genetic ablation of CXCR3, the receptor for CXCL10, CXCL9 and CXCL11, showed increased survival, decreased lung inflammation and less invasion following infection, depending on the pneumococcal inoculation strain used 47 . Moreover, addition of exogenous CXCL10 prior to infection of mice with influenza virus or respiratory syncytial virus increased pneumonia severity 48 .
Our results support previous findings from mouse models showing that CCL2 signaling and monocyte recruitment are key mediators of pneumococcal carriage clearance 16 . However, contrary to key mechanisms described in mouse models, we did not observe any production of IL-17A or neutrophil recruitment to the nose following carriage or associated with carriage clearance [15] [16] [17] , underlining the importance of confirming mouse findings with human data.
One limitation of this study is that only one pneumococcal serotype 6B isolate was used; future studies using other isolates with a more or less invasive phenotype will be able to address how generalizable these findings are across pneumococcal isolates. Nonetheless, the observation that carriage load and duration decline in parallel for all serotypes following repeated exposure suggests that immunological control of newly acquired S. pneumoniae is mediated by similar mechanisms independent of the colonizing serotype 49 . In conclusion, this study highlights the importance of innate immunity-which was impaired by pre-existing viral infectionsin the control of carriage load and clearance of S. pneumoniae. Secondary bacterial infection following viral respiratory tract infection creates a large disease burden worldwide, and disrupting viralbacterial synergy through host-directed therapy could prove an attractive addition to current therapeutic and vaccination options 50 .
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